ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

CDC Awaits Results Of Viral Cultures Of Bahama’s Serum For AIDs Contamination Before Taking Action

July 19, 1985

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008